program vaccination of persons aged ≥ 2 months at greater possibility for meningococcal illness (dosing agenda varies by age and indication, and interval for booster dose may differ by age at time of previous https://www.outlookindia.com/plugin-play/2024-%EB%B0%94%EC%B9%B4%EB%9D%BC%EC%82%AC%EC%9D%B4%ED%8A%B8-%ED%95%9C%EA%B5%AD-%EC%B5%9C%EC%B4%88-%EA%B2%80%EC%A6%9D-top3